Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma

Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma

BackgroundPemphigus vulgaris (PV) is a rare and severe autoimmune blistering disorder affecting the skin and mucous membranes, characterized by the production of autoantibodies against two desmosomal adhesion proteins, desmoglein 1 and 3. In patients with advanced squamous cell carcinoma of the skin...

Full description

Bibliographic Details
Main Authors:	Rosalba Buquicchio, Valentina Mastrandrea, Sabino Strippoli, Davide Quaresmini, Michele Guida, Raffaele Filotico
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Oncology
Subjects:	Pemphigus vulgaris desmoglein immune check-point inhibitors cemiplimab anti-programmed-death-1 cutaneous squamous cell carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.691980/full

Similar Items

Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?
by: Fariba Iraji, et al.
Published: (2016-01-01)

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
by: Maryam Mobarakabadi, et al.
Published: (2019-12-01)

Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent
by: Pawel Pietkiewicz, et al.
Published: (2018-08-01)

Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris
by: Robert Pollmann, et al.
Published: (2019-06-01)

Localized pemphigus exacerbation associated with underlying breast cancer
by: Roberto Maglie, MD, et al.
Published: (2020-12-01)

Effects of pemphigus vulgaris serum on expression of Dsg and MMP-9 in HaCaT cells
by: Zhi-min XIE, et al.
Published: (2020-10-01)

Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation
by: Zhimin Xie, et al.
Published: (2023-11-01)

Phosphorylated p38 mitogen-activated kinase in patients with pemphigus vulgaris: a case–controlled study
by: Shereen A Sobeih, et al.
Published: (2020-01-01)

The value of trichoscopy in the differential diagnosis of scalp lesions in pemphigus vulgaris and pemphigus foliaceus
by: Marta Sar-Pomian, et al.
Published: (2014-12-01)

Pemphigus Vulgaris: Application of Occlusal Soft Splint with Topical Steroid in the Treatment
by: G Vivekanandh Reddy, et al.
Published: (2011-01-01)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
by: Giulio Fortuna, et al.
Published: (2021-11-01)

T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus
by: Christoph Hudemann, et al.
Published: (2023-05-01)

Innate immune activation as cofactor in pemphigus disease manifestation
by: Ramona A. Eichkorn, et al.
Published: (2022-07-01)

Dysphagia and history of vegetative plaques
by: Anna Catinis, BA, et al.
Published: (2022-03-01)

The cutaneous form of pemphigus vulgaris of the pemphigus chancre type: clinical and therapeutic implications
by: Natalia Welc, et al.
Published: (2024-02-01)

Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: A Potential Therapeutic Target
by: Maedeh Kheirodin, et al.
Published: (2022-07-01)

Pemphigus vulgaris
by: Adriana Maria Porro, et al.
Published: (2019-07-01)

Conjunctivitis, mucosal erosions, and moist cutaneous plaques
by: Caroline A. Nelson, MD, et al.
Published: (2018-03-01)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
by: Ines Lakoš Jukić, et al.
Published: (2023-07-01)

Potential correlation of oral flora with pemphigus vulgaris – A case control study
by: Bing-jie Li, et al.
Published: (2023-10-01)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
by: Giulia Di Lullo, et al.
Published: (2019-06-01)

Case report: Documentation of cutaneous only pemphigus vulgaris without history of mucosal lesions in North America
by: John Baker, et al.
Published: (2022-09-01)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
by: Isabela Soubhia Corral, et al.
Published: (2013-08-01)

Pemphigus Vulgaris in the Mouth and Esophageal Mucosa
by: Angelo Gualberto de Macedo, et al.
Published: (2018-06-01)

Case report: A rare case of imiquimod-induced atypical pemphigus vulgaris
by: Francesco Moro, et al.
Published: (2022-11-01)

Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature
by: Rebecca Mergler, et al.
Published: (2017-04-01)

Efficacy of Rituximab in Patients with Autoimmune Bullous Disease: A Retrospective Cohort Study
by: Özge Aşkın, et al.
Published: (2021-01-01)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023-12-01)

Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin
by: Thomas Schmitt, et al.
Published: (2022-05-01)

Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
by: Hanieh Zargham, MD, et al.
Published: (2022-08-01)

Expression of HLA-G in the Skin of Patients with Pemphigus Vulgaris
by: Fathemeh Yari, et al.
Published: (2008-03-01)

Treatment-naïve pemphigus patients showing IgG tissue deposits have serum IgG antibodies against desmoglein 1 detected more often than those against desmoglein 3: a monocentre laboratory experience
by: Magdalena Jałowska, et al.
Published: (2023-06-01)

A rare new presentation of pemphigus vulgaris
by: Nikoo Mozafari, et al.
Published: (2022-06-01)

Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
by: Ambreen Rehman, et al.
Published: (2021-06-01)

Efficacy of combination therapy of steroid and methotrexate for refractory pemphigus
by: Miwa Kanaoka, et al.
Published: (2021-10-01)

Taiwanese dermatological association (TDA) consensus for the management of pemphigus
by: Chia-Yu Chu, et al.
Published: (2023-07-01)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
by: Maxi Hofrichter, et al.
Published: (2018-09-01)

Subtype transition from pemphigus vulgaris to pemphigus foliaceus
by: Ty Gilkey, BS, et al.
Published: (2023-01-01)

Pemphigus vulgaris
by: Vijeev Vasudevan, et al.
Published: (2008-01-01)

Acquired Hemophilia in Associaton With Pemphigus Vulgaris;An Uncommon Coexistence: A Case Report
by: Kamran Balighi, et al.
Published: (2021-10-01)